Healthy Minds

UN Relations have been developed to begin Phase 1 clinical studies on a variety of hallucinogenic compounds in a controlled setting.

Schedule 1 drug clearance protocol has been approved to study the following active chemical compounds.  



An active compound found in "Magic" Mushrooms, this chemical has been shown to increase neural plasticity. 



Commonly found in the Peyote Cactus to treat addiction with a success rate of over 95% in controlled clinical settings. 


Lysergic Acid 

LSD was used for the first time in 2017 in a clinical study within the UK with a 98% success rate treating depression. 



DMT found in Ayahuasca is known as the Spirit molecule. Almost all user's report an improved quality of life after using the compound. 

Mental Disorder's affect over 3 billion people. Hallucinogenic compounds in a controlled clinical setting are a viable neuropsychological treatment. 

Spirit Mental .png